A recall of <"https://www.yourlawyer.com/practice_areas/defective_drugs">Tylenol Arthritis Pain Caplets has been expanded to include all available product lots of Tylenol Arthritis Pain Caplet 100 count bottles, with the distinctive red EZ-OPEN CAP.
In November, Johnson & Johnson’s McNeil Consumer Healthcare unit recalled 5 lots of this Tylenol product because of reports of an unusual moldy, musty, or mildew-like odor that was associated with nausea, stomach pain, vomiting and diarrhea. According to a notice posted on the Food & Drug Administration (FDA) Web site, the original recall is being expanded as a precautionary measure.
According to McNeil Consumer Healthcare, the uncharacteristic smell associated with recalled Tylenol Arthritis Pain Caplets is caused by the presence of trace amounts of a chemical called 2,4,6-tribromoanisole. The source of 2,4,6-tribromoanisole is believed to be the breakdown of a chemical used to treat wooden pallets that transport and store packaging materials. The health effects of this compound have not been well studied, but McNeil said that so far, to date all of the reported adverse reactions have been temporary and non-serious.
A list of the lots included in this recall can be found here. The affected Tylenol Arthritis Pain Caplet 100 count product lot numbers can be found on the side of the bottle label.
Only the Tylenol Arthritis Pain Caplet 100â€™s with the distinctive red EZ-OPEN CAP are affected by this action. All other Tylenol Arthritis Pain products remain commercially available. McNeil Consumer Healthcare said it will reintroduce the Tylenol Arthritis Pain Caplet 100 count product by January, 2010 after moving production to a new facility
Consumers who purchased Tylenol Arthritis Pain Caplet 100 count bottles with the distinctive red EZ-OPEN CAP from the lots included in this recall should stop using the product and contact McNeil for instructions on a refund or replacement. For these instructions or information regarding how to return or dispose of the product, consumers should call 1-888-222-6036 (Monday-Friday 8 a.m. to 8 p.m. Eastern Time, and Saturday-Sunday 9 a.m. to 5 p.m. Eastern Time) or log on to the internet at www.tylenol.com.
Consumers who have medical concerns or questions should contact their healthcare provider. Any adverse reactions may also be reported to the FDAâ€™s MedWatch Program by fax at 1-800-FDA-0178, by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at www.fda.gov/medwatch.